EMILIO
ESTEBAN GONZALEZ
Profesor Titular de Universidad
![Foto de EMILIO](/img/nophoto.png)
![Foto de Samsung Medical Center](/img/noimage_org.png)
Samsung Medical Center
Seúl, Corea del SurSamsung Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2014
-
Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma
Journal of Clinical Oncology, Vol. 32, Núm. 8, pp. 760-767